Dr James Shannon joins Circassia's board
This article was originally published in Scrip
Executive Summary
Circassia, a UK-based speciality biopharmaceutical company focused on allergy, has appointed Dr James Shannon, former head of global development at Novartis Pharma, to its board of directors.